In our study, we wanted to verify our hypothesis that depending on glucose availability and molecular context, BMI-1 can differently affect the activation of the AKT pathway by regulation of PTEN or PHLPP isoform expression in endometrial cancer cells. This evidence concerns the gene AKT1 and endometrial cancer.